Testing drug combinations for pancreatic cancer

Lead Researcher: Professor Greg Neely

Institution: The University of Sydney (NSW)

Funding Duration: 2017-2019

‍

The Research

Study to define how drug resistance can develop at the whole genome scale. Using this data, we will predict and test new combination drugs that can overcome cancer drug resistance, or avoid developing resistance in the first place.